An interventional study of Breath analysis in Respiratory Tract Infections (RTI), sponsored by Hopital Foch. Not yet recruiting at 3 sites in France. Open to participants aged 1 Month and older. Per ClinicalTrials.gov, last updated 2026-07-06.
Sponsored by Hopital Foch · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 49 studies in Respiratory Tract Infections with a site in France — 18 open to participants now, 18 under way, 4 of them phase 3. Respiratory Tract Infections · France.
Among the 49 studies in Respiratory Tract Infections with a site in France, this one is the 12th largest by planned enrollment of the 32 interventional ones that give a count, is one of 12 that started in 2026, is one of 18 with no phase, reaches primary completion later than 10 of the 17 other live ones, and was the 48th registered.
753 studies on the registry are indexed under Respiratory Tract Infections; 112 are open to participants now.
Browse Respiratory Tract Infections studies →18 of the 49 studies in Respiratory Tract Infections with a site in France are open now. Recruiting first, the newest first:
Givaudan France Naturals · Sites in France
Ages 18–65 · Healthy volunteers
Institut National de la Santé Et de la Recherche Médicale, France · Sites in France
Centre Hospitalier Annecy Genevois · Sites in France
Ages 18+ · Healthy volunteers
University Hospital, Grenoble · Sites in France, United States, Germany and 2 more countries
Ages 60+
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 1+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 73 Respiratory Tract Infections studies recruiting now, 33 (45%) set no upper age limit and 32 (44%) stop at 75 or younger; 34 take children under 18; 23 take healthy volunteers.
This study: 1 Month and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
49 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 12 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 450 is above the median of 200 across 542 interventional studies indexed under Respiratory Tract Infections.
Median enrollment 301 across the 32 interventional studies, 124 across the 17 observational. Of the 29 that completed or were terminated, 5 (17%) have results posted.
This tab as a report to print or save as PDF → With an account.
16 of 49 have an industry lead sponsor. The 10 most frequent:
Hopital Foch is the lead sponsor of 215 studies on the registry; 21 are open to participants now.
Hopital Foch has 1 study filed under Respiratory Tract Infections — fewer than ten, so there is no comparison to draw.
7 of the studies in Respiratory Tract Infections with a site in France that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07013474Phase 3PfizerA Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised | 2027-09-28 |
| NCT05624450Phase 3AstraZenecaEfficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen | 2027-11-04 |
| NCT06197152Assistance Publique - Hôpitaux de ParisIdentification and Clinical Validation of Biomarkers Associated With Clinical Severity in Adults Infected With RSV | 2026-12 |
| NCT07787130Givaudan France NaturalsEffect of Immune X on Common Cold Incidence in Healthy Adults | 2027-03-01 |
| NCT07625683Laboratoires ElerteObservational Study of SIROPSEDAL in Acute Cough | 2027-05-31 |
Add all 7 to your calendar (.ics) → With an account.
Among the 49 studies in Respiratory Tract Infections with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Lower respiratory tract infections (LRTIs) remain a major global health burden, with diagnosis often challenged by clinical heterogeneity, overlapping symptoms, difficulty in obtaining quality biological specimens and limitations of conventional microbiological testing. Exhaled breath contains thousands of volatile organic compounds (VOCs), arising from both host metabolism and microbial activity, and provides a non-invasive window into the metabolic landscape of infection. Emerging evidence from in vitro studies, animal models, and clinical investigations supports the existence of pathogen-specific VOC signatures. However, most published studies have relied on offline methods, such as gas chromatography-mass spectrometry (GC-MS), and robust proof-of-concept for real-time, bedside analysis in diverse, real-world populations is lacking. Proton transfer reaction-mass spectrometry (PTR-MS) offers rapid, quantitative, and non-invasive assessment of breath VOCs in both spontaneously breathing and mechanically ventilated patients.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Breath analysis and respiratory sample collection
Diagnostic Test: Breath analysis
breath sampling and collection and analysis (microscopic analysis, cultures and syndromic panel of a respiratory sample
Infection test
Breath VOC signature for patient categorical classification of LRTI (infection / colonization / none)
Time frame: Day 0
Pathogen class test
Breath VOC signature differentiating bacterial and viral infections
Time frame: Day 0
Pathogen ID test
Breath VOC signature differentiating major respiratory pathogens
Time frame: Day
Diagnostic performance
Sensitivity, specificity, negative predictive value, positive predictive value, area under the ROC curve, accuracy of each test compared to reference standards
Time frame: Day 0
Antimicrobial susceptibility test
Breath VOC signature differentiating susceptibility and resistance of a given pathogen to a given antibiotic (exploratory outcome).
Time frame: Day 0
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Jun 2026; primary completion for Dec 2027, 18 months later.
Of 119 non-industry interventional studies with no phase under Respiratory Tract Infections, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 30. This study's planned 18 months is above that.
Counting every sponsor, half of 146 studies reached it within 12 months; a quarter within 6 and three quarters within 29.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Respiratory Tract Infections →